Universidad de Costa Rica
12
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Comparison of Carotenoid Bioavailability From Fresh Papaya, Tomato and Carrot
Role: collaborator
Promoting Early Language Development Through Parent-child Book Reading in Costa Rica
Role: lead
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)
Role: collaborator
Video Gaming for Home Rehabilitation for Children With Hemiplegic Cerebral Palsy in Costa Rica
Role: collaborator
Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients
Role: collaborator
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
Role: collaborator
C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon Cancer
Role: lead
Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica
Role: lead
Bioavailability of Carotenoids Present in Mamey Sapote (Pouteria Sapota (Jacq.) H. E. Moore & Stearn) Fruit
Role: collaborator
Intervention for Women in Costa Rica
Role: collaborator
A Case-control Study of Costa Rican Adults With Myocardial Infarction
Role: collaborator
Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrición y Salud
Role: collaborator
All 12 trials loaded